Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03484338 · ClinicalTrials.gov registry record · NA
Accelerated Resolution Therapy for Complicated Grief
A NA study of Depressive Symptoms and Trauma, Psychological, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT03484338: Completed NA study of Depressive Symptoms and Trauma, Psychological, sponsored by University of South Florida.
NCT03484338 is a NA study of Depressive Symptoms and Trauma, Psychological that has completed, run by University of South Florida. The registered enrollment target is 54 participants, below the 261-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03484338, a NA study of Depressive Symptoms and Trauma, Psychological, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether accelerated resolution therapy (ART) is effective for the treatment of prolonged and complicated grief and associated psychological trauma among older adult hospice caregivers who have experienced the death of an immediate family member at least 12 months ago.
Primary Outcome
Response on the 19-item Inventory of Complicated Grief (ICF) over the course of the 4-week intervention period. Scores range from 0-76 with a score \>24 indicating presence of complicated grief.
Conditions Studied
Interventions
- BEHAVIORAL Accelerated Resolution Therapy
Study Locations (1)
Florida
- Harleah Buck - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2018-02-20 |
| Est. Completion | 2019-10-30 |
| Phase | NA |
What the finished NCT03484338 record still lists
NCT03484338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 261-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (79% lower).
The record links to 3 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Accelerated Resolution Therapy is the first listed.
NCT03484338 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03484338 about?
NCT03484338 is a clinical study titled "Accelerated Resolution Therapy for Complicated Grief". This study will examine whether accelerated resolution therapy (ART) is effective for the treatment of prolonged and complicated grief and associated psychological trauma among older adult hospice caregivers who have experienced the death of an immediate family member at least 12 months ago.
What is the current status of trial NCT03484338?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2018-02-20. Estimated completion is 2019-10-30.
What conditions does trial NCT03484338 study?
This clinical trial studies the following conditions: Depressive Symptoms, Trauma, Psychological, Grief.
What interventions are being tested in trial NCT03484338?
The interventions under investigation include: Accelerated Resolution Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03484338?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03484338 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03484338's enrollment target sits among peer trials
54 47th of 60 higher than 14 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI